Can devices for adult male circumcision help bridge the implementation gap for HIV prevention services?

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 5, 2011, Pages 506-508

  McIntyre, James A ^a,b  

^a ANOVA HEALTH INSTITUTE   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Africa; HIV; male circumcision

Indexed keywords

ANTIRETROVIRUS AGENT;

AFRICA; ARTICLE; CIRCUMCISION; DISEASE TRANSMISSION; DORSAL SLIT METHOD; FORCEPS GUIDED METHOD; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MALE CIRCUMCISION DEVICE; MEDICAL INSTRUMENTATION; MORTALITY; PAPILLOMAVIRUS INFECTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; SKILL; SLEEVE RESECTION METHOD; SURGICAL TECHNIQUE;

AFRICA; CIRCUMCISION, MALE; DEVELOPING COUNTRIES; HEALTH MANPOWER; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PUBLIC HEALTH PRACTICE; SEXUAL BEHAVIOR;

EID: 81755173551     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318237af5d     Document Type: Article

References (19)

1. The Economist. The End of AIDS. The Economist. London, United Kingdom: The Economist Newspaper Ltd; June 2, 2011.
2. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363:2587-2599.
3. Baeten JM, Celum C. Partners PREP Study Team Antiretroviral preexposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study [MOAX0106]. Presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17-20, 2011; Rome, Italy.
4. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
6. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.
7. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet. 2007;369:643-656. (Pubitemid 46281312)
8. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657-666.
9. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199:958-964.
10. Wawer MJ, Tobian AA, Kigozi G, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 2011;377:209-218.
11. Hallett TB, Alsallaq RA, Baeten JM, et al. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect. 2011;87:88-93.
12. World Health Organization, UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. Geneva, Switzerland: World Health Otrganization; 2007.
13. Hankins CA. 2007-2011: State of the VMMC scale up [SUSA14]. Presented at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17-20, 2011; Rome, Italy.
14. South African National AIDS Council. National Strategic Plan for HIV and AIDS, STIs and TB, 2012-2016. Draft Zero for Consultation. Pretoria, South Africa: South African Department of Health; 2011.
15. Padian NS, McCoy SI, Karim SS, et al. HIV prevention transformed: the new prevention research agenda. Lancet. 2011; 378:269-278.
16. World Health Organization. Considerations for implementing models for optimizing the volume and efficiency of male circumcision services. Field testing edition. Geneva, Switzerland: World Health Organization; 2010.
17. Auvert B, Taljaard D, Rech D, et al. Effect of the Orange Farm (South Africa) male circumcision roll-out (ANRS-12126) on the spread of HIV [WELBC02]. Presented at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17-20, 2011; Rome, Italy.
18. Farley T. Adult MC device update and WHO approval process for medical devices [SUSA14]. Presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17-20, 2011; Rome, Italy.
19. Barone MA, Ndede F, Li PS, et al. The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr. 2011;57:E7-E12.